Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.

The purpose of this study is to test if adding one infusion of (Human Mesenchymal Stem Cells) hMSCs to the treatment with standard of care (SOC) monoclonal antibodies (mAb) will stabilize the rate of cognitive and functional decline associated with mild Alzheimer's Disease.

Participants needed: 10
Trial details
Phase: Phase 2Age: 55-90Biological sex: AllType: InterventionalSponsor: Bernard (Barry) BaumelUpdated: May 28, 2026Locations: 1
Eligibility criteria

Adults 55-90 years at the time of signing consent [+4]

Dementia other than AD [+10]

Status: Recruiting

Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.

The purpose of this research study is to test if adding one infusion of mesenchymal stem cells to the current treatment with antipsychotic medication may help control behavioral problems in people with a diagnosis of moderate to severe Alzheimer's disease.

Participants needed: 8
Trial details
Phase: Phase 2Age: 55-90Biological sex: AllType: InterventionalSponsor: Bernard (Barry) BaumelUpdated: May 28, 2026Locations: 1
Eligibility criteria

Adults 55-90 years at the time of signing consent [+7]

Dementia other than AD [+9]